Lamotrigine is a medication approved to treat two main conditions: epilepsy and bipolar I disorder. First approved in the United States in 1994, it has become one of the most widely prescribed options for both seizure control and mood stabilization, largely because it works well and is generally tolerable compared to older alternatives.
Epilepsy and Seizure Control
Lamotrigine is considered a first-line treatment for several types of seizures. It is approved as an add-on therapy for children aged 2 and older, and as a standalone treatment for adults 16 and older. The specific seizure types it treats include partial-onset seizures (which start in one area of the brain), primary generalized tonic-clonic seizures (the type most people picture when they think of a seizure, involving full-body convulsions), and the generalized seizures associated with Lennox-Gastaut syndrome, a severe form of childhood epilepsy.
For adults already taking another seizure medication, lamotrigine can serve as a replacement rather than just an addition. It is approved for conversion to monotherapy in people switching from older seizure drugs like carbamazepine, phenytoin, or valproate.
Bipolar I Disorder
Lamotrigine is approved for maintenance treatment of bipolar I disorder, meaning it is taken long-term to delay the return of mood episodes, including depression, mania, hypomania, and mixed states. This is an important distinction: it is not used to treat acute manic or depressive episodes as they’re happening. Instead, it acts as a preventive measure after an acute episode has already been managed with other treatments.
Clinical evidence shows lamotrigine lowers the risk of mood episode recurrence compared to placebo, and it performs comparably to lithium, the traditional gold standard for bipolar maintenance. Where it may have an edge is in its safety profile. It carries fewer long-term side effects than lithium, particularly regarding kidney and thyroid function, and appears safer during pregnancy. Many clinicians consider it especially useful for preventing depressive episodes, which tend to be the most disabling part of bipolar I for many patients.
Off-Label Uses
Lamotrigine is sometimes prescribed off-label for bipolar depression, meaning it’s used to help manage depressive episodes even though it doesn’t carry a formal approval for that specific purpose. Some clinicians also use it for other conditions, though the evidence base is strongest for its approved indications in epilepsy and bipolar disorder.
How Lamotrigine Works in the Brain
Lamotrigine calms overactive electrical signaling in the brain through several mechanisms. Its primary action is blocking voltage-gated sodium channels, which are tiny gates on nerve cells that open to let electrical signals pass through. By binding to these channels when they’re in a resting state after firing, lamotrigine selectively quiets neurons that are firing too rapidly or erratically, the kind of activity that drives seizures. Crucially, it does this without significantly dampening normal brain activity, which is why many people tolerate it better than older seizure medications.
Beyond sodium channels, lamotrigine also reduces the release of glutamate and aspartate, two brain chemicals that ramp up neuronal excitability. It blocks certain calcium channels and may increase the activity of GABA, the brain’s main calming neurotransmitter. This combination of effects helps explain why it works across such different conditions. In epilepsy, it prevents the runaway electrical storms that cause seizures. In bipolar disorder, it stabilizes the neural circuits involved in mood regulation.
Starting the Medication: Why It Takes Weeks
One of the most distinctive things about lamotrigine is how slowly it must be started. The conventional approach begins at 25 mg per day and doubles roughly every one to two weeks, typically taking 8 weeks or more to reach the usual maintenance dose of 200 mg per day. This gradual ramp-up exists for a specific safety reason: starting too high or increasing too fast significantly raises the risk of serious skin reactions.
This slow titration can feel frustrating, especially for people who want relief quickly. But the timeline is non-negotiable from a safety standpoint. Your prescriber will give you a specific schedule, and sticking to it closely matters more with this medication than with most others.
Skin Rash and Serious Reactions
The most talked-about risk with lamotrigine is skin rash. In a large review of over 18,000 patients across 122 clinical trials, about 8.3% developed some type of skin reaction. The vast majority of these rashes are mild and resolve on their own or after stopping the medication.
The serious concern is Stevens-Johnson syndrome, a rare but potentially life-threatening condition where the skin and mucous membranes blister and peel. This occurs in roughly 0.04% of patients, or about 1 in every 2,500 people treated. While rare, the consequences are severe enough that any new rash while starting lamotrigine should be evaluated promptly. The slow dose escalation described above is the main strategy for minimizing this risk.
Interactions With Birth Control
Estrogen-containing oral contraceptives have a significant and often underappreciated effect on lamotrigine. Taking the pill increases the body’s clearance of lamotrigine by about 84%, meaning the drug is broken down and eliminated much faster than usual. This can drop blood levels enough to trigger breakthrough seizures in people with epilepsy or destabilize mood in those with bipolar disorder.
The interaction also works in reverse during the placebo week of a birth control pack, when estrogen levels fall. Lamotrigine levels can then spike, potentially increasing side effects. If you take both medications, your prescriber will likely need to adjust your lamotrigine dose and may recommend a non-estrogen contraceptive method instead.
Use During Pregnancy
For people who need seizure or mood control during pregnancy, lamotrigine is one of the safer options available. Data from the North American Antiepileptic Drug Pregnancy Registry, spanning 1997 through 2023, shows no heightened risk of major birth defects with lamotrigine exposure during the first trimester. This stands in contrast to valproate, phenobarbital, and topiramate, all of which do carry increased risks. Lamotrigine is frequently used as a reference point in pregnancy safety studies precisely because of its favorable track record.
That said, pregnancy itself changes how the body processes lamotrigine. Blood levels tend to drop as pregnancy progresses, so dose adjustments are common and blood level monitoring is typically recommended throughout.
Use in Children
Lamotrigine is approved as an add-on epilepsy treatment for children aged 2 and older. Dosing in children is weight-based, and the specific amount depends heavily on what other medications the child is taking. Children on valproate, for example, start at much lower doses (as low as 0.15 mg per kilogram per day) because valproate slows lamotrigine’s breakdown. Children on other seizure medications may need higher doses. The same slow titration principle applies to pediatric patients, with the goal of reaching an effective dose while minimizing rash risk.